Table 2.
Characteristics of Liver Transplant Candidates by Transplant Status
| Transplanted | Not Transplanted | Died | P-value* | |
|---|---|---|---|---|
| No. Enrolled | ||||
| HIVTR | 58 (35%) | 85 (51%) | 24 (14%) | N/A |
| UNOS | 377 (48%) | 327 (41%) | 88 (11%) | N/A |
| Median (IQR) Age (yr) | ||||
| HIVTR | 47 (42–52) | 47 (43–51) | 50 (41–55) | 0.85 |
| UNOS | 48 (43–52) | 50 (44–54) | 49 (43–54) | 0.09 |
| Race (Caucasian) | ||||
| HIVTR | 41 (71%) | 68 (80%) | 16 (67%) | 0.34 |
| UNOS | 275 (73%) | 239 (73%) | 69 (78%) | 0.80 |
| Sex Male | ||||
| HIVTR | 44 (76%) | 71 (84%) | 21 (88%) | 0.39 |
| UNOS | 309 (82%) | 254 (78%) | 75 (85%) | 0.19 |
| Median (IQR) Baseline CD4 | ||||
| HIVTR | 315 (229–437) | 264 (189–399) | 237 (146–348) | 0.03 |
| UNOS | - | - | - | |
| No (%) Detectable HIV RNA | ||||
| HIVTR | 9 (16%) | 6 (7%) | 5 (21%) | 0.09 |
| UNOS | - | - | - | |
| No. (%)HCV infection | ||||
| HIVTR | 47 (81%) | 60 (71%) | 18 (75%) | 0.37 |
| UNOS | 277 (73%) | 253 (77%) | 62 (70%) | 0.30 |
*
For tests comparing Transplanted, Not Transplanted and Died groups within cohort.